Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 2/3 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × nilutamide × Clear all
NCT00003653 2021-06-23

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
1,386 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002633 2020-04-03

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
361 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Completed
306 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡